— Know what they know.
Not Investment Advice

AUGX NASDAQ

Augmedix, Inc.
1W: +0.4% 1M: +1.7% 3M: +135.0% 1Y: -55.3% 3Y: -55.2%
$2.35
Last traded 2024-10-02 — delisted
NASDAQ · Healthcare · Medical - Healthcare Information Services · $115.9M mcap · 25M float · 3.22% daily turnover

Balance Sheet Trends

Total Assets
$67M +98.3% ▲
5Y CAGR: +36.6%
Total Liabilities
$43M +34.9% ▲
5Y CAGR: +14.1%
Shareholders Equity
$23M +1490.8% ▲
Cash & Investments
$46M +110.8% ▲
5Y CAGR: +36.1%
Total Debt
$27M +30.8% ▲
5Y CAGR: +14.9%
Net Debt
-$19M -818.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$10M$21M$42M$22M$46M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$10M$21M$42M$22M$46M
Net Receivables$2M$3M$7M$6M$9M
Inventory$2M$0-$2M-$2M$0
Other Current Assets$0$2M$460K$2M$2M
Total Current Assets$14M$27M$49M$28M$57M
Property, Plant & Equip.$1M$992K$982K$3M$9M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$207K$612K$0
Other Non-Current Assets$173K$173K$2M$2M$930K
Total Non-Current Assets$1M$1M$3M$5M$10M
Total Assets$16M$28M$52M$34M$67M
— Liabilities —
Accounts Payable$641K$259K$1M$2M$721K
Short-Term Debt$3M$7M$2M$5M$6M
Deferred Revenue$7M$6M$6M$7M$9M
Other Current Liabilities$1M$2M$3M$3M$3M
Total Current Liabilities$13M$16M$8M$9M$24M
Long-Term Debt$10M$8M$13M$11M$15M
Other Non-Current Liab.$58M$0$668K$509K$421K
Total Non-Current Liabilities$68M$8M$20M$23M$20M
Total Liabilities$81M$25M$28M$32M$43M
— Equity —
Common Stock$198$3K$4K$4K$5K
Retained Earnings-$68M-$84M-$102M-$126M-$145M
Accumulated OCI-$41K-$52K-$70K-$440K-$919K
Total Stockholders Equity-$65M$3M$24M$1M$23M
Total Liabilities & Equity$16M$28M$52M$34M$67M
— Key Metrics —
Total Debt$13M$15M$15M$20M$27M
Net Debt$3M-$6M-$27M-$2M-$19M
Total Investments$0$0$207K$612K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms